Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bohmer

Showing results (361-370 of 379) with videos related to

Pageof 38
Sort By:
Alzheimer'S Research & Therapy|December 5, 2025
International consensus for the assessment of social cognition in neurocognitive disorders: framework definition and clinical recommendations of the SIGNATURE initiativeAlessandra Dodich, Andrea Panzavolta, Giulia Funghi, et al.
Kidney International|December 29, 2024
Resazurin dye is an in vivo sensor of kidney tubular functionShirely Acosta Martinez, Isaac Z Karel, Josie A Silvaroli, et al.
Cell Chemical Biology|July 8, 2025
Plasmodiumfalciparum protein kinase 6 and hemozoin formation are inhibited by a type II human kinase inhibitor exhibiting antimalarial activityFlore Nardella, Tiantian Jiang, Lushun Wang, et al.
Haematologica|December 1, 2020
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trialMartine E D Chamuleau, Coreline N Burggraaff, Marcel Nijland, et al.
American Journal of Human Genetics|March 5, 2002
Age at onset in two common neurodegenerative diseases is genetically controlledYi-Ju Li, William K Scott, Dale J Hedges, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 24, 2020
Risk Governance of Emerging Technologies Demonstrated in Terms of its Applicability to NanomaterialsPanagiotis Isigonis, Antreas Afantitis, Dalila Antunes, et al.
Haematologica|April 16, 2026
Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL studyMarie José Kersten, Martin Dreyling, Kim M Linton, et al.
The Lancet. Neurology|February 21, 2026
A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USAEric M Reiman, Robert C Alexander, Jessica B Langbaum, et al.
European Journal of Cancer (Oxford, England : 1990)|October 20, 2024
Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapiesFleur A de Groot, Tim J A Dekker, Jeanette K Doorduijn, et al.
Nature Genetics|February 16, 2010
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusionsVivianna M Van Deerlin, Patrick M A Sleiman, Maria Martinez-Lage, et al.
Pageof 38

Showing results (361-370 of 379) with videos related to

Sort By:
Pageof 38
Alzheimer'S Research & Therapy|December 5, 2025
International consensus for the assessment of social cognition in neurocognitive disorders: framework definition and clinical recommendations of the SIGNATURE initiativeAlessandra Dodich, Andrea Panzavolta, Giulia Funghi, et al.
Kidney International|December 29, 2024
Resazurin dye is an in vivo sensor of kidney tubular functionShirely Acosta Martinez, Isaac Z Karel, Josie A Silvaroli, et al.
Cell Chemical Biology|July 8, 2025
Plasmodiumfalciparum protein kinase 6 and hemozoin formation are inhibited by a type II human kinase inhibitor exhibiting antimalarial activityFlore Nardella, Tiantian Jiang, Lushun Wang, et al.
Haematologica|December 1, 2020
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trialMartine E D Chamuleau, Coreline N Burggraaff, Marcel Nijland, et al.
American Journal of Human Genetics|March 5, 2002
Age at onset in two common neurodegenerative diseases is genetically controlledYi-Ju Li, William K Scott, Dale J Hedges, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 24, 2020
Risk Governance of Emerging Technologies Demonstrated in Terms of its Applicability to NanomaterialsPanagiotis Isigonis, Antreas Afantitis, Dalila Antunes, et al.
Haematologica|April 16, 2026
Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL studyMarie José Kersten, Martin Dreyling, Kim M Linton, et al.
The Lancet. Neurology|February 21, 2026
A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USAEric M Reiman, Robert C Alexander, Jessica B Langbaum, et al.
European Journal of Cancer (Oxford, England : 1990)|October 20, 2024
Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapiesFleur A de Groot, Tim J A Dekker, Jeanette K Doorduijn, et al.
Nature Genetics|February 16, 2010
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusionsVivianna M Van Deerlin, Patrick M A Sleiman, Maria Martinez-Lage, et al.
Pageof 38